NASDAQ:PRCT

Procept Biorobotics Stock News

etoro logo Buy PRCT
*Your capital is at risk
$16.69
-0.86 (-4.90%)
At Close: Jul 24, 2026
SAN JOSE, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative s
Chicago Capital sold 377,850 shares of PRCT in the fourth quarter; the estimated transaction value was $12.53 million based on quarterly average pricing. Meanwhile, the quarter-end position value decl
SAN JOSE, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing tran
CES 2026 proved humanoid robots are production-ready. Our analysis of Atlas, Optimus and NEO, plus 11 top supply chain plays.
PROCEPT BioRobotics Corporation (NASDAQ: PRCT - Get Free Report) traded down 7.1% during trading on Friday. The company traded as low as $32.76 and last traded at $32.0470. 89,791 shares changed hands
Every once in a while, a secular trend is so obvious that everyone can see it, and that is the case with AI. Drones are another important secular trend that we believe will benefit many areas of the e
The global robotics industry is among the fastest-growing, with projections that it will expand from $50 billion worldwide in 2025 to $111 billion in just five years. Technology develops at a rapid p
Frontier Capital Management Co. LLC increased its holdings in PROCEPT BioRobotics Corporation (NASDAQ: PRCT) by 94.7% during the undefined quarter, according to the company in its most recent disclosu
Federated Hermes Inc. boosted its holdings in PROCEPT BioRobotics Corporation (NASDAQ: PRCT) by 4.8% during the second quarter, according to the company in its most recent disclosure with the SEC. The
SAN JOSE, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative s
The portfolio generated a modestly positive absolute return in Q3, but it trailed the MSCI All Country World Small Mid Index. The Q3 underperformance was driven by stock selection in the IT, financial
PROCEPT BioRobotics Corporation ( PRCT ) Q3 2025 Earnings Call November 4, 2025 4:30 PM EST Company Participants Matthew Bacso - Vice President of Investor Relations Larry Wood - President, CEO & Dire
PROCEPT BioRobotics Corporation (PRCT) came out with a quarterly loss of $0.38 per share versus the Zacks Consensus Estimate of a loss of $0.41. This compares to a loss of $0.4 per share a year ago.
SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing tr
State of New Jersey Common Pension Fund D raised its stake in shares of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) by 9.9% in the undefined quarter, according to its most recent 13F filing with th
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE